Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Endobronchial Metastases × Sugammadex × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1

Conditions

Brain Neoplasms 2 Urologic Neoplasms 1 Strabismus 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Post-operative Residual Curarization 1 Neuromuscular Blockade 1 Endobronchial Metastases 1 Emergence Delirium 1

Interventions

remimazolam 1 Sugammadex 1 Rocuronium 1 Remifentanil 1 Propofol 1 Oxycodone 1 Flumazenil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05468671 2022-10-26

Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy

Zhejiang Cancer Hospital

Phase 4 Completed

GastrointestinalThoracic

Endobronchial Metastases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡